Systemic Immun Inflamation Score Corelation in Postoperative Patients Prognosis

The Systemic Immuno-Inflammation Index (SII) is a ratio derived from complete blood count parameters (neutrophils, lymphocytes, platelets) and is a non-invasive and easily calculable biomarker. The SIPI effectively reflects both local and systemic inflammatory responses in the human body. It has been used to predict and evaluate the prognosis of various solid tumors such as gastric cancer, non-small cell lung cancer, and colorectal cancer. Furthermore, the SIPI has been shown to have significant prognostic value in cardiovascular and cerebrovascular diseases. In this study, the SIPI will be calculated using laboratory data at the time of admission to the intensive care unit, and the relationship between the obtained values and the 30-day mortality status of the patients will be analyzed.

NCT Number	NCT07544719
Lead Sponsor	Malatya Egitim Ve Arastirma Hastanesi
Conditions	Geriatric Anesthesia, Postop Adult ICU Patients
Enrollment	150 participants
Start Date	2026-06-15
Primary Completion	2026-07-15 (estimated)
Study Completion	2026-07-30 (estimated)
Updated on ClinicalTrials.gov	2026-04-22